“…In most studies, the focus is developing microfluidic devices for LAMP‐based assays. However, microfluidic devices are expensive to fabricate, complex to use, and require trained personnel and stable operation conditions, which makes this technology not feasible for field‐deployable real‐time diagnosis (Almassian et al, 2013, de Oliveira et al, 2021, El‐Tholoth et al, 2021, Ganguli et al, 2020, Kaymaz & Elitas, 2021, Ma et al, 2018, Mori et al, 2001, Wan et al, 2017, Wan et al, 2019). Therefore, portable, rapid, cost‐effective, automated, and remotely controllable LAMP platforms with colorimetric readouts will be the future of field‐ready modern nucleic‐acid‐based detection platforms (Kaygusuz et al, 2019, Ludwing et al, 2021, Puri et al, 2021, Xun et al, 2021).…”